Webinars
Strategies to Accelerate the Path to Clinic for Next-Generation Antibodies
Summary: Experts discuss formulation development and purification strategies to increase throughput, reduce operating costs and decrease...
View Now
Article
What’s Next for mRNA? From COVID to Cancer & Beyond
Summary: During this Q&A, we discuss the challenges of mRNA development and manufacturing, potential solutions and where the industry may go next with mRNA therapies.
View Now
Executive Summary
The Path to Self-Administration: Considerations for Moving from Pre-Filled Syringe to Auto-Injector
Summary: In this executive summary, Catalent Biologics offers advice to pharma companies on three key areas of auto-injector device development.
View Now
Webinars
Leveraging Proven Technology to Speed Path to First-In-Human Studies with GPEx® Lightning
Summary: During this talk, hear the latest data leveraging GPEx Lightning to generate highly stable, highly productive cell pools and discuss how the GPEx...
View Now
Offering Fact Sheet
Drug Product Manufacturing – Europe Infocard
Summary: Catalent Biologics’ drug product operations in Europe can formulate, fill and finish sterile products into a vial, syringe, or cartridge injectable format for clinical and...
View Now
Webinars
How Lessons Learned from COVID-19 Pandemic Will Improve Vaccine Development in the Future
Summary: This webinar offers tips for incorporating elements of the successful COVID-19 vaccine rollout into future vaccine programs.
View Now
Article
Transitioning from Vial to Prefilled Syringe: How Formulation Development Affects Manufacturing
Summary: Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS).
View Now
Webinars
Introducing GPEx® Lightning: Next Gen Cell Line Engineering to Speed Your Path to Clinic
Summary: During this talk, we share the latest data leveraging GPEx Lightning to generate highly stable, highly productive cell pools and discuss how the GPEx suite of technologies can be tailored to the specific needs of each individual program on its path to clinical trials.
View Now
Webinars
Manufacturing of New Modalities: New Opportunities Come With New Challenges
Summary: Dr. Mahdavi’s talk reviews key growth areas, innovative technologies and future strategies designed to increase the efficiency and scalability of advanced therapeutics.
View Now
Webinars
The Post-COVID Pipeline Takes Shape: New Vaccines and Drugs During the mRNA Revolution
Summary: In this webinar, leaders in the field discuss new vaccines and drugs that have resulted from COVID and key learnings to prepare for the next pandemic.
View Now
